MedTrace Logo

Trial of Antihypertensive Intervention Management

NCT00000513 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2013-11-26

No results posted yet for this study

Summary

The objective of the Trial of Antihypertensive Intervention Management (TAIM) was to determine the efficacy of dietary management and/or drug therapy, namely thiazide-like diuretics or a beta-blocker, in the control of mild hypertension. Additionally, the Continuation of the Trial of Antihypertensive Intervention Management (COTAIM) tested the effects of long-term weight reduction, and sodium/potassium changes added to weight reduction, as well as the original drug treatment, on the failure rate of blood pressure control.

Conditions

Interventions

BEHAVIORAL

diet, reducing

BEHAVIORAL

diet, sodium-restricted

DRUG

chlorthalidone

DRUG

atenolol

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    lead NIH

Principal Investigators

  • Morton Blaufox · Albert Einstein College of Medicine

  • Kent Kirchner · University of Mississippi Medical Center

  • Albert Oberman · University of Alabama at Birmingham

  • Sylvia Wassertheil-Smoller · Albert Einstein College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1984-04-30
Completion
1994-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000513 on ClinicalTrials.gov